A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB‐FHbp

Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents

(2019) Timo Vesikari et al.   VACCINE

National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018

(2019) Tanja Y. Walker et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Patterns of Primary Care Physician Visits for US Adolescents in 2014: Implications for Vaccination

(2018) Cynthia M. Rand et al.   Academic Pediatrics

Knowledge and Attitudes Regarding Category B ACIP Recommendations Among Primary Care Providers for Children

(2018) Allison Kempe et al.   Academic Pediatrics

Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine

(2018) Lisa K. McNeil et al.   mBio

Evaluation of Mass Vaccination Clinics in Response to a Serogroup B Meningococcal Disease Outbreak at a Large, Public University—Oregon, 2015

(2018) Emily A. Fisher et al.   JOURNAL OF ADOLESCENT HEALTH

Adoption of Serogroup B Meningococcal Vaccine Recommendations

(2018) Allison Kempe et al.   PEDIATRICS

The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci

(2018) Shannon L. Harris et al.   VACCINE

Meningococcal Disease Among College-Aged Young Adults: 2014–2016

(2018) Sarah A. Mbaeyi et al.   PEDIATRICS

Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak

(2018) Blair Capitano et al.   Human Vaccines & Immunotherapeutics

Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak—Oregon, 2015–2016

(2017) Lucy A McNamara et al.   JOURNAL OF INFECTIOUS DISEASES

Expanding state laws and a growing role for pharmacists in vaccination services

(2017) Cason D. Schmit et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults

(2017) Lars Ostergaard et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Need to Optimize Adolescent Immunization

(2017) Henry H. Bernstein et al.   PEDIATRICS

Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine

(2017) Amanda C. Cohn et al.   PEDIATRICS

Understanding the Category B Recommendation for Serogroup B Meningococcal Vaccine

(2017) Gary S. Marshall et al.   PEDIATRICS

Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France

(2017) Muhamed-Kheir Taha et al.   VACCINE

Novel approaches to Neisseria meningitidis vaccine design

(2017) Myron Christodoulides et al.   Pathogens and Disease

Serogroup B Meningococcus Outbreaks, Prevalence, and the Case for Standard Vaccination

(2017) James Grogan et al.   Current Infectious Disease Reports

Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016

(2017) Monica E. Patton et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States

(2017) Gowrisankar Rajam et al.   mSphere

Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci

(2016) Serena Giuntini et al.   Clinical and Vaccine Immunology

A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents

(2016) Derek Muse et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine

(2016) Shelly Senders et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older

(2016)   PEDIATRICS

History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention

(2016) Bruce Atkinson et al.   PHARMACOTHERAPY

Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®)

(2016) Ashesh Gandhi et al.   POSTGRADUATE MEDICINE

A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults

(2016) Lars Ostergaard et al.   VACCINE

Impact of pharmacists as immunizers on vaccination rates: A systematic review and meta-analysis

(2016) J.E. Isenor et al.   VACCINE

Clinical experience with the meningococcal B vaccine, Bexsero ® : Prospects for reducing the burden of meningococcal serogroup B disease

(2016) Philip S. Watson et al.   VACCINE

Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents

(2016) Timo Vesikari et al.   Journal of the Pediatric Infectious Diseases Society

Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine

(2015) Raffaella Rossi et al.   Clinical and Vaccine Immunology

Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults

(2015) Roger Baxter et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015

(2015) Jessica R. MacNeil et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents

(2015) Timo Vesikari et al.   Journal of the Pediatric Infectious Diseases Society

Feasibility of a Pharmacy-Based Influenza Immunization Program in an Academic Emergency Department

(2014) Victor Cohen et al.   ANNALS OF PHARMACOTHERAPY

Antibody Persistence and Booster Response of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents

(2014) Roger Baxter et al.   JOURNAL OF PEDIATRICS

The Discovery and Development of a Novel Vaccine to Protect againstNeisseria meningitidisSerogroup B Disease

(2014) Gary W Zlotnick et al.   Human Vaccines & Immunotherapeutics

Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States

(2011) Xin Wang et al.   VACCINE

A decade of experience with an inpatient pneumococcal vaccination program

(2010) J. T. Robke et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Meningococcal carriage by age: a systematic review and meta-analysis

(2010) Hannah Christensen et al.   LANCET INFECTIOUS DISEASES

Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease

(2010) Han-Qing Jiang et al.   VACCINE

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

(2009) Carl E. Frasch et al.   VACCINE

Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide

(2009) Lisa K. McNeil et al.   VACCINE